To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Global E-Prescription Market size was valued at USD 2.28 billion in 2021 and is poised to grow from USD 2.89 billion in 2022 to USD 24.5 billion by 2030, growing at a CAGR of 26.8% in the forecast period (2023-2030).

Global E-Prescription Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Cerner Corporation', 'Allscripts Healthcare Solutions, Inc.', 'DrFirst, Inc.', 'Surescripts', 'Practice Fusion, Inc.', 'Medical Information Technology, Inc. (MEDITECH)', 'Henry Schein Medical Systems, Inc.', 'Athenahealth, Inc.', 'Change Healthcare', 'eClinicalWorks', 'GE Healthcare', 'Quality Systems, Inc.', 'Epic Systems Corporation', 'NextGen Healthcare', 'Computer Programs and Systems, Inc. (CPSI)', 'McKesson Corporation', 'AdvancedMD, Inc.', 'Vitera Healthcare Solutions, LLC', 'Greenway Health LLC', 'RXNT'

Increasing Initiatives to Eliminate Adverse Drug Events (ADEs) and Medical Errors

The market will grow greatly as a result of the e-prescribing software being integrated into EHR solutions. Clinical notes, laboratory data, and a wide spectrum of clinical decision assistance are just a few benefits of integrated EHRs that standalone systems do not have. E-prescription with connected EHRs improves patient medication histories and pharmacy benefits information availability, making potentially life-saving drug data instantly accessible. Prescription mistakes have been significantly decreased by EHR-based systems in community-based medical practises, which has increased product adoption and boosted market growth over the course of the projection period. Another important element boosting the market is the government’s growing initiatives to deploy integrated EHR across numerous hospitals.

North America dominated the market in 2021, owing to the healthcare industry’s growing digitalization, favourable government policies, and a flexible regulatory environment. Regional expansion will also be aided in the predicted period by rising private and public investment for the implementation of integrated EHRs. For instance, the Cooperative Agreement Notice of Funding Opportunity was published by the Office of the National Coordinator for Health Information Technology (ONC) (NOFO). This program’s goal is to make it possible for the technical standards required to achieve interoperability among healthcare IT systems to advance.

Feedback From Our Clients

Global E-Prescription Market

Product ID: SQMIG35F2007